RSS
Логотип
Баннер в шапке 1
Баннер в шапке 2

Mesoformula

Company

History

2024: Launch of the production of drugs for injectable aesthetic medicine for 390 million rubles

In mid-August 2024, the production of innovative drugs for injectable aesthetic medicine and professional cosmetology opened in Moscow. The project was implemented by Mesoformula, a resident of the Technopolice Moscow special economic zone. Total investments in it amounted to ₽390 million.

The new enterprise is aimed at import substitution and plans to supply products not only to the Russian market, but also to the markets of friendly foreign countries. The project includes the production of biorevitalizants, mesotherapy products, chemical peeling preparations, peptide complexes and professional cosmetics of the cosmeceutical level - a segment that combines cosmetology and pharmaceuticals.

In Moscow, for 390 million rubles, launched the production of drugs for injectable aesthetic medicine

As the Deputy Mayor of Moscow for Transport Maxim Liksutov clarified, the design capacity of the new enterprise allows the production of more than 700 thousand units of products per year. The production complex includes a research and development (R&D) laboratory, a sterile production site with a capacity of up to 600 thousand units of products per year, as well as a cosmetics and mask production site with a capacity of up to 125 thousand units per year. More than 20 new jobs have been created in production, which is a significant contribution to the city's economy.

In addition, the company's products comply with international GMP standards, which is confirmed by the presence of marketing authorizations and international certificates of conformity.

According to the Minister of the Government of Moscow, the head of the Moscow Department of Investment and Industrial Policy Anatoly Garbuzov, the company placed production on an area of ​ ​ 1.5 thousand square meters on the territory of the Pechatniki site of the SEZ Technopolice Moscow. A high level of production automation and compliance with international standards will ensure the production of high-quality products.[1]

2022: Expansion of product supplies to the countries of Transcaucasia and Central Asia

Since the beginning of 2022, the resident of the special economic zone of Moscow, the Mesoformula company has expanded the geography of supplies of its products to the countries of Transcaucasia and Central Asia. This was announced on November 1, 2022 by the head of the Department of Investment and Industrial Policy of the city of Moscow Vladislav Ovchinsky.

File:Aquote1.png
A resident of the capital's SEZ, which produces drugs for aesthetic medicine, has expanded the geography of export of injectable drugs and cosmetics. In 2022, the company began deliveries to Azerbaijan, Armenia and Uzbekistan. As of November 2022, the company's products are exported to seven countries, - added Vladislav Ovchinsky.
File:Aquote2.png

Potential partners from Iran and Iraq are showing great interest in products. In the future, the company plans to increase supplies in these areas and is already negotiating future contracts.

File:Aquote1.png
We export hyaluronic acid preparations for cosmetic injection procedures - mesotherapy and biorevitalization. These products help to improve skin condition even in such serious diseases as acne, rosacea and alopecia. Also in the line there are drugs to combat age-related involution changes: mimic wrinkles and hyperpigmentation, - said Nadezhda Kapleva, General Director of Mesoformula.
File:Aquote2.png

One of the advantages of the products of the resident of the SEZ "Technopolice Moscow" are complex balanced formulations of drugs that are as close as possible to the biological structure of the skin. In addition, exposure to drugs is local, which means that it is effective in the field of use.

File:Aquote1.png
Thanks to its own research and development and certification of products at the international level, the company is actively increasing exports. In 2019, the company began deliveries to Kuwait and Qatar. In 2021, the company delivered injectable drugs to Kyrgyzstan and Moldova and is now expanding cooperation with Middle Eastern countries. This is also facilitated by customs and tax resident benefits, - said Gennady Degtev, General Director of the Technopolice Moscow SEZ.
File:Aquote2.png

The production site of the Mesoformula company is located in Pechatniki on an area of ​ ​ more than 1.5 thousand square meters. Until 2024, the company intends to invest to develop its production on the territory of the SEZ Moscow about 250 million. rubles This will create about 50 jobs and bring the volume of products sold to 1 billion rubles in 2025.